Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
FR-104 by Veloxis Pharmaceuticals for Kidney Transplant Rejection: Likelihood of Approval
FR-104 is under clinical development by Veloxis Pharmaceuticals and currently in Phase I for Kidney Transplant Rejection. According to GlobalData,...